Oral administration of recombinant epinecidin-1 protected grouper (Epinephelus coioides) and zebrafish (Danio rerio) from Vibrio vulnificus infection and enhanced immune-related gene expressions
- Authors
- Pan, C.Y., Huang, T.C., Wang, Y.D., Yeh, Y.C., Hui, C.F., and Chen, J.Y.
- ID
- ZDB-PUB-120507-8
- Date
- 2012
- Source
- Fish & shellfish immunology 32(6): 947-957 (Journal)
- Registered Authors
- Chen, Jyh-Yih
- Keywords
- Epinecidin-1, immune response, Danio rerio, Epinephelus coioides, Vibrio vulnificus
- MeSH Terms
-
- Adjuvants, Immunologic/administration & dosage*
- Administration, Oral
- Animals
- Antimicrobial Cationic Peptides/administration & dosage*
- Antimicrobial Cationic Peptides/genetics
- Antimicrobial Cationic Peptides/immunology
- Escherichia coli/genetics
- Fish Diseases/immunology
- Fish Diseases/prevention & control*
- Fish Proteins/administration & dosage*
- Fish Proteins/genetics
- Fish Proteins/immunology
- Gene Expression Regulation/drug effects*
- Perciformes/genetics
- Perciformes/immunology*
- Recombinant Proteins/administration & dosage
- Recombinant Proteins/genetics
- Recombinant Proteins/immunology
- Vibrio Infections/prevention & control
- Vibrio Infections/veterinary*
- Zebrafish/genetics
- Zebrafish/immunology*
- PubMed
- 22554570 Full text @ Fish Shellfish Immunol.
Immunostimulatory effects of the oral administration of the recombinant epinecidin-1 protein from BL21 Escherichia coli (containing the pET28a-epinecidin-1-dsRed plasmid) were studied in grouper (Epinephelus coioides) and zebrafish (Danio rerio). For this purpose, fish were fed diets for 30 days containing the recombinant epinecidin-1 protein from BL21 E. coli (containing the pET28a-epinecidin-1-dsRed plasmid) at different bacterial numbers (104, 106, 108, and 1010 colony-forming units (cfu) of BL21 E. coli in 50 ml of LB medium) mixed with 50 g of eel powder as fodder. After 30 days of feeding, immune-related gene expressions for bacterial-infection responses and disease resistance against Vibrio vulnificus (204) were determined. The V. vulnificus (204) injected into the fish abdominal cavity mimicked gram-negative bacterial infections in culture ponds. Experimental results assessed whether the recombinant epinecidin-1 protein from BL21 E. coli (containing the pET28a-epinecidin-1-dsRed plasmid) has up- (or down-) regulation immune-related genes expression. Results indicated that the recombinant epinecidin-1 protein from BL21 E. coli administered as a feed supplement significantly enhanced expressions several immune-related genes such as tumor necrosis factor (TNF)-1 in grouper and Toll-like receptor (TLR)4, interleukin (IL)-1β, nitric oxide synthase (NOS)2, and nuclear factor (NF)-κB in zebrafish. After being challenged with V. vulnificus (204) for 24, 48, 72, or 96 h, the percentage mortality was significantly reduced in treated fish, which indicated that the recombinant epinecidin-1 protein from BL21 E. coli administered as a feed supplement could bring about downregulation of TNF-1 expression and functioned like an antagonist for binding TLR4, which reduced the signal transduction pathway for inhibiting TNF and IL-1β expressions while reducing binding of the transcription factor, NF-κB, to TNF and the IL-1β promoter region. The experimental results indicated that dietary intake of the recombinant epinecidin-1 protein from BL21 E. coli modulated immune-related gene expressions and disease resistance of grouper and zebrafish after a V. vulnificus (204) infection.